Advertisement
Screener

Korro Bio, Inc. (KRRO) Graph

2.8 / 5 stars · 68/120 Roast Me

KRRO Revenue Flow

KRRO Graph summary

Korro Bio, Inc. (KRRO). Quarter ended 2022-09-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.

How Korro Bio, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.00B $0.02B$-0.02B$0.01B$0.01B$-0.02B$0.00B$-0.00B$-0.02B Revenue from contracts with customers, excluding assessed tax$0.00BDeclared revenue$0.00B Operating expenses$0.02BOperating income$-0.02BResearch and development$0.01BGeneral and administrative$0.01BOther income, net$0.00BPre-tax income$-0.02BIncome tax$-0.00BNet income$-0.02B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atrium Therapeutics, Inc. (RNA)United States$0.140B
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Annexon, Inc. (ANNX)United States$0.147B-4.22
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Advertisement